Suqin Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suqin Zhang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Chun-Dong Zhang
Department of Surgical Oncology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China
1 shared publication - Hua Wang
Shanghai University
1 shared publication Jianhua Zhou
Department of Traditional Chinese Medicine, Shanghai Eighth People's Hospital
1 shared publicationPeng Lian
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center
1 shared publication- Peng Zan
School of Medicine, Shanghai University, Shanghai, China
1 shared publication Tao Huang
Department of Gastrointestinal Surgery, Shanghai Eighth People's Hospital, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 19 February 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (7) , e24322
Effect of Quxie capsule in patients with colorectal cancer
Objective: To investigate whether the Quxie capsule can decrease relapse, metastasis, and symptoms, as well as alleviate the side effects in colorectal cancer (CRC) patients. Methods: A comprehensive literature search of multiple databases was performed. Two reviewers independently selected trials that assessed the relapse-metastasis rate, degree of symptoms, and side effects of Quxie capsule for CRC. The meta-analysis was performed using Review Manager 5.3. Results: This meta-analysis included 6 studies, with a total of 408 cases. The quality of the included studies was generally low, with only 1 trial of high quality. A statistically significant difference was observed in the relapse-metastasis rate between the Quxie capsule and control groups after 2-years follow-up (n = 185, relative risk (RR) = 0.13, 95% confidence interval (CI) 0.04–0.46; P = .002). The Quxie capsule was found to reduce the traditional Chinese medicine symptom score as compared to the control (n = 208, weighted mean differences (WMD) = −4.15, 95% CI −7.30 to −1.00; P = .010), while it showed no significant improvement in the Karnofsky Performance Status score (n = 138, WMD = 5.05; 95% CI −2.95 to 13.04; P = .22). There was no difference in adverse events between the 2 groups (P = .66). Conclusion: This systematic review and meta-analysis showed no clear superiority of Quxie capsule for CRC patients receiving chemotherapy. The effect of Quxie capsule in CRC patients should be examined by high quality, large sample size, multi-center RCTs, with longer follow-up.
- 19 February 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (7) , e24322
Open AccessEffect of Quxie capsule in patients with colorectal cancer
Objective: To investigate whether the Quxie capsule can decrease relapse, metastasis, and symptoms, as well as alleviate the side effects in colorectal cancer (CRC) patients. Methods: A comprehensive literature search of multiple databases was performed. Two reviewers independently selected trials that assessed the relapse-metastasis rate, degree of symptoms, and side effects of Quxie capsule for CRC. The meta-analysis was performed using Review Manager 5.3. Results: This meta-analysis included 6 studies, with a total of 408 cases. The quality of the included studies was generally low, with only 1 trial of high quality. A statistically significant difference was observed in the relapse-metastasis rate between the Quxie capsule and control groups after 2-years follow-up (n = 185, relative risk (RR) = 0.13, 95% confidence interval (CI) 0.04–0.46; P = .002). The Quxie capsule was found to reduce the traditional Chinese medicine symptom score as compared to the control (n = 208, weighted mean differences (WMD) = −4.15, 95% CI −7.30 to −1.00; P = .010), while it showed no significant improvement in the Karnofsky Performance Status score (n = 138, WMD = 5.05; 95% CI −2.95 to 13.04; P = .22). There was no difference in adverse events between the 2 groups (P = .66). Conclusion: This systematic review and meta-analysis showed no clear superiority of Quxie capsule for CRC patients receiving chemotherapy. The effect of Quxie capsule in CRC patients should be examined by high quality, large sample size, multi-center RCTs, with longer follow-up.
- 25 August 2017
- Published by Springer Nature
- p. 3-12
Research of Rectal Pressure Signal Preprocessing Based on Improved FastICA Algorithm
- 25 August 2017
- Published by Springer Nature
- p. 3-12
Research of Rectal Pressure Signal Preprocessing Based on Improved FastICA Algorithm